Literature DB >> 29907706

Widespread Effects of Chemokine 3' Untranslated Regions on mRNA Degradation and Protein Production in Human Cells.

Wenxue Zhao1,2, David J Erle1.   

Abstract

Chemokines are a large family of chemotactic cytokines that play critical roles in inflammation, development, and diseases. Chemokine expression is highly regulated during development and in response to environmental stimuli. The 3' untranslated regions (3'-UTRs) of mRNA are believed to be important in the control of chemokine gene expression. However, the regulatory effects of most chemokine 3'-UTRs have not been characterized previously. In this work, we systematically studied the effects of 43 CC and CXC chemokine 3'-UTRs on gene expression in eight human cell lines and two types of human primary cells. We found that chemokine 3'-UTRs had a wide spectrum of regulatory effects on mRNA abundance and protein production that were tightly correlated with the effects on mRNA stability. In general, 3'-UTRs had remarkably similar effects across all cell types studied. The presence of AU-rich elements, microRNA targets, and Pumilio binding sites were associated with chemokine 3'-UTR activity but did not fully account for all 3'-UTR activity detected using the reporter assay. Mutational analysis illustrated how specific cis-regulatory elements contributed to the regulatory effect of chemokine 3'-UTRs. These findings bring new insights into the mechanisms by which chemokine expression is regulated by 3'-UTRs.
Copyright © 2018 by The American Association of Immunologists, Inc.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29907706      PMCID: PMC6057839          DOI: 10.4049/jimmunol.1800114

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  55 in total

Review 1.  Chemokine and chemoattractant receptor expression: post-transcriptional regulation.

Authors:  Thomas A Hamilton; Michael Novotny; Shyamasree Datta; Palash Mandal; Justin Hartupee; Julie Tebo; Xiaoxia Li
Journal:  J Leukoc Biol       Date:  2007-04-04       Impact factor: 4.962

2.  Proliferating cells express mRNAs with shortened 3' untranslated regions and fewer microRNA target sites.

Authors:  Rickard Sandberg; Joel R Neilson; Arup Sarma; Phillip A Sharp; Christopher B Burge
Journal:  Science       Date:  2008-06-20       Impact factor: 47.728

3.  Enforcing temporal control of maternal mRNA translation during oocyte cell-cycle progression.

Authors:  Karthik Arumugam; Yiying Wang; Linda L Hardy; Melanie C MacNicol; Angus M MacNicol
Journal:  EMBO J       Date:  2009-12-03       Impact factor: 11.598

4.  HIV-1 matrix protein p17 promotes angiogenesis via chemokine receptors CXCR1 and CXCR2.

Authors:  Francesca Caccuri; Cinzia Giagulli; Antonella Bugatti; Anna Benetti; Giulio Alessandri; Domenico Ribatti; Stefania Marsico; Paola Apostoli; Mark A Slevin; Marco Rusnati; Carlos A Guzman; Simona Fiorentini; Arnaldo Caruso
Journal:  Proc Natl Acad Sci U S A       Date:  2012-08-17       Impact factor: 11.205

5.  Mammalian microRNAs predominantly act to decrease target mRNA levels.

Authors:  Huili Guo; Nicholas T Ingolia; Jonathan S Weissman; David P Bartel
Journal:  Nature       Date:  2010-08-12       Impact factor: 49.962

Review 6.  Regulation of chemokine activity by posttranslational modification.

Authors:  Anneleen Mortier; Jo Van Damme; Paul Proost
Journal:  Pharmacol Ther       Date:  2008-08-28       Impact factor: 12.310

7.  Functional analysis of KSRP interaction with the AU-rich element of interleukin-8 and identification of inflammatory mRNA targets.

Authors:  Reinhard Winzen; Basant Kumar Thakur; Oliver Dittrich-Breiholz; Meera Shah; Natalie Redich; Sonam Dhamija; Michael Kracht; Helmut Holtmann
Journal:  Mol Cell Biol       Date:  2007-10-01       Impact factor: 4.272

8.  ARED 3.0: the large and diverse AU-rich transcriptome.

Authors:  Tala Bakheet; Bryan R G Williams; Khalid S A Khabar
Journal:  Nucleic Acids Res       Date:  2006-01-01       Impact factor: 16.971

9.  Chemokine requirements for B cell entry to lymph nodes and Peyer's patches.

Authors:  Takaharu Okada; Vu N Ngo; Eric H Ekland; Reinhold Förster; Martin Lipp; Dan R Littman; Jason G Cyster
Journal:  J Exp Med       Date:  2002-07-01       Impact factor: 14.307

10.  CRISPR-Cas9-mediated functional dissection of 3'-UTRs.

Authors:  Wenxue Zhao; David Siegel; Anne Biton; Olivier Le Tonqueze; Noah Zaitlen; Nadav Ahituv; David J Erle
Journal:  Nucleic Acids Res       Date:  2017-10-13       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.